Daniel Contreras on 10th Oct

Exelixis and Pfizer compete for the best cancer treatment

The new cancer drug Cabometyx surpassed the drug Sutent, which could make it a first-line treatment of metastatic kidney...

Read More
Irene Rondon on 06th Jun

Oxycodone can be extracted from Pfizer’s opioid painkiller

According to a preliminary review by the U.S. Food and Drug Administration (FDA), Pfizer’s long-acting opioid painkiller...

Read More
Daniel Contreras on 11th Mar

FDA expands use of Pfizer drug for a rare form of lung cancer

On Friday, the U.S. Food and Drug Administration (FDA) expanded the use of Xalkori, a drug commercialized by Pfizer, to...

Read More
Daniel Contreras on 06th Feb

Pfizer Betting $15 Billion on New Generic Drugs

According to reports, Pfizer plans to spend $15 billion on a new and more elite class of generic drugs, which are complex...

Read More